Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

4.030 -0.180 (-4.28%)
Streaming Delayed Price Updated: 3:50 PM EST, Nov 3, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 29,494
Open 4.130
Bid (Size) 4.000 (200)
Ask (Size) 4.110 (1,000)
Prev. Close 4.210
Today's Range 4.011 - 4.130
52wk Range 1.001 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
+8.0%
+8.0%
1 Month
-5.2%
-5.2%
3 Month
-22.6%
-22.6%
6 Month
-7.4%
-7.4%
1 Year
+253.5%
+253.5%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 4.030
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 11/03/25 03:50 PM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 8.40B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.